🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Haleon PLC stock dips after Pfizer's $3.26 bln stake sale

Published 10/01/2024, 05:12 AM
PFE
-
HLN
-
HLN
-

Investing.com -- Shares of Haleon PLC (LON:HLN) (NYSE:HLN) traded lower on Tuesday after Pfizer (NYSE:PFE) had sold a substantial stake in the British consumer healthcare group.

The U.S. pharmaceutical giant offloaded about $3.26 billion worth of shares, reducing its ownership in Haleon to 15% from 22.6%, Reuters reported on Tuesday. 

This move comes as Pfizer continues its strategy of gradually divesting its stake in Haleon, which was established through the merger of GSK and Pfizer's consumer healthcare businesses in 2019 and spun off from GSK in 2022.

The company had previously indicated its intention to decrease its stake in a "slow and methodical" manner, suggesting a planned and considered approach to the divestment process, the report said.

In total, Pfizer aimed to sell about 540 million shares, but due to strong demand, this figure was raised by 100 million shares. In addition to Pfizer's sale, Haleon said it would buy back about 60.5 million of its own shares from Pfizer at the same price, totaling around £230 million.

Investment banks BofA Securities and Goldman Sachs International acted as joint global coordinators and bookrunners for the sale, the report added. 

This is not the first time Pfizer has divested shares in Haleon; earlier this year, in March, it sold about $3.5 billion worth of Haleon shares. Additionally, GSK completely exited its stake in Haleon in May.

Haleon has projected strong performance, forecasting high single-digit growth in organic operating profit for 2024, driven by demand for its oral care products and vitamins. 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.